The University of Texas Health Science Center, Houston
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center, Houston sits in the top decile of US sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center, Houston: 732 sponsored US clinical trials, 144 recruiting.
The University of Texas Health Science Center, Houston sponsors 732 registered US clinical trials on ClinicalTrials.gov, 144 of them currently recruiting, and 436 completed. 98 of these trials are in Phase 3-4 (later-stage) and 139 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 8 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center, Houston ranks in the top decile of sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
436 of 521 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
732 total, page 14 of 15
Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
NCT00762892
Early Parkinson's Disease (PD) Cross-Sectional
NCT00817453
CLOTBUST Hands-Free: A Phase I/II Pilot Safety Trial
NCT01240356
Outcomes of Mechanically Ventilated Patients With Low Serum Testosterone
NCT00797433
Pilot Study of Diet and Behavior in Children With Autism
NCT01625299
Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes
NCT00678080
Anticipation of the Difficult Airway: the Preoperative Airway Assessment Form
NCT01037374
Use of Adult Autologous Stem Cells in Treating People Who Have Had a Heart Attack (The TIME Study)
NCT00684021
Screening for Obstructive Sleep Apnea Among Members of an Internet Weight Loss Community
NCT00808574
Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study)
NCT00684060
Initiation of Colon Cancer Screening in Veterans or "Start Screening Now"
NCT01079533
Lunch is in the Bag: Helping Parents Increase Fruit, Vegetables, and Whole Grains in Preschool Sack Lunches
NCT01292434
A Comparison of the Infant Truview EVO2 Video Laryngoscope and the Macintosh Laryngoscope in Pediatric Patients
NCT00803751
Reducing Environmental Tobacco Smoke in Neonatal Intensive Care Unit (NICU) Infants' Homes
NCT00670280
Improving Ambulation Post Stroke With Robotic Training
NCT00975156
Corticosteroid Therapy on Glucose Control in Pregnant Women With Diabetes
NCT00673543
Pressure Ulcer Prevention: Turning for Ulcer Reduction
NCT00665535
Comparison of I-gel to the Laryngeal Mask Airway
NCT00706823
AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS
NCT00617383
Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence
NCT00713583
An Evaluation of Motivational Interviewing to Increase Compliance in a Probation Setting
NCT00570206
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
NCT00581425
Evaluation of the Rapid Airway Management Positioner
NCT00581230
Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients
NCT00918073
The Role of Arnica on Muscle Pain Following Eccentric Exercise
NCT00504010
Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation
NCT00524394
Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD)
NCT00514202
Improving Teamwork for Neonatal Resuscitation
NCT00651794
Clinical Comparison of the Airway Devices
NCT00581386
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
NCT00364104
Prevention of Surgical Site Infections
NCT00353613
Correlation Salivary Cortisol and Free Serum Cortisol to Total Serum Cortisol in MICU Septic Shock
NCT00523198
Rapid Characterization of Paucibacillary TB Along Tex/Mex Border
NCT00421798
Thrombin Generation and Thromboelastography in Non-overt DIC
NCT00299949
Southern Methodist Alcohol Research Trial (SMART)
NCT00374153
All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School Students
NCT00167505
Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO
NCT00371241
Acceptance Therapy During Methadone Detoxification
NCT00439036
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
NCT00218036
Dexmedetomidine vs. Remifentanil for Sedation During AFI
NCT00349245
Elastographic Imaging of Renal Transplants
NCT00935727
Does LMA Instead of ET Tube Affect Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction?
NCT00338559
The Impact of Texas Senate Bill 42 on Middle School Children's Level of Physical Activity
NCT00672815
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023
Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals
NCT00218062
Ambu® Laryngeal Mask as an Intubation Conduit
NCT00272194
Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury
NCT00178711
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
NCT00178503
Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis
NCT00178789
Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
NCT00217997
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 55 |
| Phase 2 | 84 |
| Phase 3 | 13 |
| Phase 4 | 85 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center, Houston pipeline
144 recruiting of 732 indexed (20% open); 436 completed (60%).
Phase mix: 98 late (III/IV) vs 139 early (I/II) (balanced across stages).
Top condition: Stroke (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center, Houston: open-pipeline peers nationwide
Peers matched on 732 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center, Houston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 732 trials (± recruiting share)
- University of Miami · 721 trials · 20% recruiting
- Sanofi · 713 trials · 10% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- University of Chicago · 20% recruiting · 796 trials
Related
What to do with this The University of Texas Health Science Center, Houston page
732 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center, Houston or any single study.
- 144 of The University of Texas Health Science Center, Houston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition The University of Texas Health Science Center, Houston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center, Houston pipeline card: 732 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.